Want to see CH:SOON full AI Analyst Report?
SOON Stock Chart & Stats
CHF211.40
CHF6.60(3.12%)
At close: 4:00 PM EDT
CHF211.40
CHF6.60(3.12%)
Day’s Range― - ―
52-Week RangeCHF163.00 - CHF245.80
Previous CloseN/A
Volume187.47K
Average Volume (3M)194.70K
Market Cap
CHF13.98B
Enterprise ValueCHF12.74B
Total Cash (Recent Filing)CHF722.10M
Total Debt (Recent Filing)CHF1.71B
Price to Earnings (P/E)33.8
Beta0.83
Next Earnings
Nov 12, 2026EPS Estimate
4.37Next Dividend Ex-DateN/A
Dividend Yield1.92%
Share Statistics
EPS (TTM)7.23
Shares Outstanding59,626,810
10 Day Avg. Volume113,155
30 Day Avg. Volume194,698
Financial Highlights & Ratios
PEG Ratio-1.22
Price to Book (P/B)4.15
Price to Sales (P/S)3.00
P/FCF Ratio17.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF221.60Price Target Upside4.82% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)10.68
Revenue Forecast (FY)CHF3.82B
Bulls Say, Bears Say
Bulls Say
Hearing Instruments Growth And Margin ExpansionThe core Hearing Instruments business is demonstrating strong operating leverage, with sales growth translating into faster profit expansion. Sustained margins and broad regional demand can support earnings resilience and fund continued product investment.
Product Innovation And Pipeline StrengthA recurring innovation pipeline strengthens Sonova’s competitive position and supports replacement demand in hearing care. AI-enabled devices, rechargeable products and planned platforms can improve differentiation, adoption and long-term growth.
Strong Cash Generation And Improving LeverageHigh cash conversion indicates that reported earnings are supported by real operating cash flow. Combined with disciplined capital spending and lower leverage, this gives Sonova flexibility for acquisitions, innovation and shareholder returns.
Bears Say
Cochlear Implants UnderperformanceWeakness in Cochlear Implants creates a drag on group growth and exposes Sonova to softer procedure volumes, lower upgrades and competitive pressure. Recovery depends on successful commercialization of the next processor platform.
Recent Revenue And Margin PressureThe latest annual slowdown shows that Sonova’s historically strong earnings profile is not immune to demand and mix pressures. Continued top-line weakness or margin compression could reduce operating leverage and temper medium-term earnings growth.
Elevated Leverage And Limited Balance-sheet StrengtheningLeverage is manageable but has not clearly improved through stronger equity accumulation. A less strengthened balance sheet could constrain financial flexibility if acquisition spending, product investment or operating pressures increase.
Sonova Holding AG News
SOON FAQ
What was Sonova Holding AG’s price range in the past 12 months?
Sonova Holding AG lowest stock price was CHF163.00 and its highest was CHF245.80 in the past 12 months.
What is Sonova Holding AG’s market cap?
Sonova Holding AG’s market cap is CHF13.98B.
When is Sonova Holding AG’s upcoming earnings report date?
Sonova Holding AG’s upcoming earnings report date is Nov 12, 2026 which is in 82 days.
How were Sonova Holding AG’s earnings last quarter?
Sonova Holding AG released its earnings results on May 18, 2026. The company reported CHF5.67 earnings per share for the quarter, missing the consensus estimate of CHF5.706 by -CHF0.036.
Is Sonova Holding AG overvalued?
According to Wall Street analysts Sonova Holding AG’s price is currently Undervalued.
Does Sonova Holding AG pay dividends?
Sonova Holding AG pays a Annually dividend of CHF4.7 which represents an annual dividend yield of 1.92%. See more information on Sonova Holding AG dividends here
What is Sonova Holding AG’s EPS estimate?
Sonova Holding AG’s EPS estimate is 4.37.
How many shares outstanding does Sonova Holding AG have?
Sonova Holding AG has 59,626,810 shares outstanding.
What happened to Sonova Holding AG’s price movement after its last earnings report?
Sonova Holding AG reported an EPS of CHF5.67 in its last earnings report, missing expectations of CHF5.706. Following the earnings report the stock price went up 7.872%.
Which hedge fund is a major shareholder of Sonova Holding AG?
Currently, no hedge funds are holding shares in CH:SOON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sonova Holding AG
Headquartered in Stäfa, Switzerland, Sonova Holding AG is a leading provider of innovative hearing care solutions for both adults and children. The company's operations are divided into two primary segments: Hearing Instruments and Cochlear Implants. Sonova's extensive offerings include advanced wireless communication devices, rechargeable hearing aids, wireless headsets, speech-enhanced hearables, premium audiophile headphones, microphones, and wireless transmission systems, alongside comprehensive audiological care services. Its renowned hearing aid brands comprise Phonak, Unitron, and Hansaton, while Advanced Bionics is its flagship for cochlear implants. For consumer audio, Sonova offers products under the Sennheiser brand. The company delivers its audiological care through a vast network of around 3,600 clinics and stores operating under various regional names such as AudioNova, Audium, and Boots Hearingcare, among others. Additionally, its products are distributed via independent partners. Sonova boasts a significant international presence, serving markets across the United States, Europe, the Middle East, Africa, and the Asia Pacific. Founded in 1947, the company was formerly known as Phonak Holding AG before officially changing its name to Sonova Holding AG in August 2007.
SOON Stock 12 Month Forecast
Average Price Target
CHF221.60
▲(4.82% Upside)
Technical Analysis
Straumann Holding AG
―
Medacta Group SA
―
Ypsomed Holding AG
―
Medartis Holding AG
―
Lepu Medical Technology (Beijing) Co., Ltd. Sponsored Global Depositary Receipt Repr Sh -A- Reg S
―





